Journal of Infection
Volume 60, Issue 4 , Pages 278-285 , April 2010

Bacteremia complicating gram-negative urinary tract infections: A population-based study

  • Majdi N. Al-Hasan

      Affiliations

    • Department of Medicine, Division of Infectious Diseases, University of Kentucky, Chandler Medical Center, 800 Rose Street, Room MN 672, Lexington, KY 40536, USA
    • Department of Medicine, Division of Infectious Diseases, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • Corresponding Author InformationCorresponding author at: Department of Medicine, Division of Infectious Diseases, University of Kentucky, Chandler Medical Center, 800 Rose Street, Room MN 672, Lexington, KY 40536, USA. Tel.: +1 859 323 8178; fax: +1 859 323 8926.
    • ,
  • Jeanette E. Eckel-Passow

      Affiliations

    • Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, College of Medicine, Mayo Clinic, Rochester, MN, USA
    • ,
  • Larry M. Baddour

      Affiliations

    • Department of Medicine, Division of Infectious Diseases, College of Medicine, Mayo Clinic, Rochester, MN, USA

,Accepted 21 January 2010.

References 

  1. Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. Community-onset urinary tract infections: a population-based assessment. Infection. 2007;35:150–153
  2. Honkinen O, Jahnukainen T, Mertsola J, Eskola J, Ruuskanen O. Bacteremic urinary tract infection in children. Pediatr Infect Dis J. 2000;19:630–634
  3. Ackermann RJ, Monroe PW. Bacteremic urinary tract infection in older people. J Am Geriatr Soc. 1996;44:927–933
  4. Dolan JG, Bordley DR, Polito R. Initial management of serious urinary tract infection: epidemiologic guidelines. J Gen Intern Med. 1989;4:190–194
  5. Bahagon Y, Raveh D, Schlesinger Y, Rudensky B, Yinnon AM. Prevalence and predictive features of bacteremic urinary tract infection in emergency department patients. Eur J Clin Microbiol Infect Dis. 2007;26:349–352
  6. US Census Bureau . Olmsted county quickfacts. http://quickfacts.census.gov/qfd/states/27/27109.html[accessed 22.12.07]
  7. Melton LJ. History of the Rochester epidemiology Project. Mayo Clin Proc. 1996;71:266–274
  8. Steckelberg JM, Melton LJ, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med. 1990;88:582–588
  9. Tleyjeh IM, Steckelberg JM, Murad HS, Anavekar NS, Ghomrawi HM, Mirzoyev Z, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted county, Minnesota. JAMA. 2005;293:3022–3028
  10. Al-Hasan MN, Wilson JW, Lahr BD, Eckel-Passow JE, Baddour LM. Incidence of Pseudomonas aeruginosa bacteremia: a population-based study. Am J Med. 2008;121:702–708
  11. Uslan DZ, Crane SJ, Steckelberg JM, Cockerill FR, St Sauver JL, Wilson WR, et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted county, Minnesota. Arch Intern Med. 2007;167:834–839
  12. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137:791–797
  13. Sarma AV, Jacobson DJ, McGree ME, Roberts RO, Lieber MM, Jacobsen SJ. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted county, Minnesota: 1987 to 1997. J Urol. 2005;173:2048–2053
  14. Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int. 2006;97(Suppl. 2):3–6[discussion 21–2]
  15. Rhodes T, Girman CJ, Jacobsen SJ, Roberts RO, Guess HA, Lieber MM. Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol. 1999;161:1174–1179
  16. Bryan CS, Reynolds KL. Community-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol. 1984;132:490–493
  17. Bryan CS, Reynolds KL. Hospital-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol. 1984;132:494–498
  18. Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Infect. 2005;50:296–305
  19. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study. Mayo Clin Proc. 2010;85(2):139–144
  20. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. J Antimicrob Chemother. 2009;64:169–174
  21. Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008;14:1041–1047
  22. Peralta G, Sanchez MB, Garrido JC, De Benito I, Cano ME, Martinez-Martinez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother. 2007;60:855–863
  23. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of gram-negative bloodstream infection in solid organ transplant recipients. Am J Transpl. 2009;9:835–843
  24. Lau SM, Peng MY, Chang FY. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. J Microbiol Immunol Infect. 2004;37:185–191
  25. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, et al. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49:760–766
  26. Bouza E, Diaz-Lopez MD, Bernaldo de Quiros JC, Rodriguez-Creixems M. Ciprofloxacin in patients with bacteremic infections. The Spanish group for the study of ciprofloxacin. Am J Med. 1989;87:228S–231S
  27. Mombelli G, Pezzoli R, Pinoja-Lutz G, Monotti R, Marone C, Franciolli M. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med. 1999;159:53–58

PII: S0163-4453(10)00022-8

doi: 10.1016/j.jinf.2010.01.007

Journal of Infection
Volume 60, Issue 4 , Pages 278-285 , April 2010

Article Tools

* Image Usage & Resolution